Caxton Associates (New York)’s Dyne Therapeutics DYN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-37,501	Closed	-$432K	–	539
2023 Q1	$432K	Buy	37,501 +1,141	+3%	+$13.1K	0.07%	283
2022 Q4	$421K	Buy	+36,360	New	+$421K	0.03%	254